OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive AI‐driven analysis of large‐scale omic datasets reveals novel dual‐purpose targets for the treatment of cancer and aging
Frank W. Pun, Geoffrey Ho Duen Leung, Hoi-Wing Leung, et al.
Aging Cell (2023) Vol. 22, Iss. 12
Open Access | Times Cited: 20

Showing 20 citing articles:

PandaOmics: An AI-Driven Platform for Therapeutic Target and Biomarker Discovery
Petrina Kamya, Ivan V. Ozerov, Frank W. Pun, et al.
Journal of Chemical Information and Modeling (2024) Vol. 64, Iss. 10, pp. 3961-3969
Open Access | Times Cited: 37

The Art of Finding the Right Drug Target: Emerging Methods and Strategies
Zi-Chang Jia, Xue Yang, Yikun Wu, et al.
Pharmacological Reviews (2024) Vol. 76, Iss. 5, pp. 896-914
Open Access | Times Cited: 14

Therapeutic targeting of senescent cells in the CNS
Markus Rießland, Methodios Ximerakis, Andrew A. Jarjour, et al.
Nature Reviews Drug Discovery (2024)
Closed Access | Times Cited: 12

TNIK’s emerging role in cancer, metabolism, and age-related diseases
Collin Y. Ewald, Fadi E. Pulous, Sarah Wing Yan Lok, et al.
Trends in Pharmacological Sciences (2024) Vol. 45, Iss. 6, pp. 478-489
Open Access | Times Cited: 5

Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
Thomas Cyberski, Alka Singh, Michael Korzinkin, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 5

PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
Vasudha Mishra, Alka Singh, Michael Korzinkin, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access

Next-gen senotherapeutics: AI/ML-driven strategies for aging and age-related disorders
Prashanth S. Javali, Ashish Kumar, S. Sarkar, et al.
Advances in pharmacology (2025)
Closed Access

Omics metabolism tools in antiaging drug discovery
Rafael Tibúrcio, Jay Rappaport, Clovis S. Palmer
Elsevier eBooks (2025), pp. 209-225
Closed Access

Leveraging AI to identify dual-purpose aging and disease targets
Geoffrey Ho Duen Leung, Chun Wai Wong, Frank W. Pun, et al.
Expert Opinion on Therapeutic Targets (2023) Vol. 28, Iss. 6, pp. 473-476
Open Access | Times Cited: 4

Utilizing AI for the Identification and Validation of Novel Therapeutic Targets and Repurposed Drugs for Endometriosis
Bonnie Hei Man Liu, Yuezhen Lin, Xi Long, et al.
Advanced Science (2024)
Open Access | Times Cited: 1

AI-enabled cancer target prioritization with optimal profiles balancing novelty, confidence and commercial tractability
Xi Long, Barbara Steurer, Chun Wai Wong, et al.
Future Medicine AI (2024) Vol. 2, Iss. 1
Open Access

Getting started with the molecular pathway analysis
Anton Buzdin, Xinmin Li
Elsevier eBooks (2024), pp. 179-202
Closed Access

Molecular data for the pathway analysis
Xinmin Li, Anton Buzdin
Elsevier eBooks (2024), pp. 43-62
Closed Access

Molecular pathway approach in biotechnology
Anton Buzdin, Denis Kuzmin, Ivana Jovčevska
Elsevier eBooks (2024), pp. 339-352
Closed Access

Analyzing research trends in glioblastoma metabolism: a bibliometric review
Jian Dai, Shiping Song, Pengyu Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Page 1

Scroll to top